Wed, Sep 28|
Option 2: Antimicrobial Resistance and Urinary Tract Infections
Objectives Explain how Antimicrobial Resistance (AMR) develops Discuss patient health, treatment options and economic implications of AMR Describe AMR and urinary tract infections (UTIs)
Time & Location
Sep 28, 2022, 7:00 p.m. – 8:00 p.m. EDT
About the event
NSWOCC & WOC Institute Continuing Education Webinar: "The science of wound healing post COVID and the role of inflammation"
- Explain how Antimicrobial Resistance (AMR) develops
- Discuss patient health, treatment options and economic implications of AMR
- Describe AMR and urinary tract infections (UTIs)
Presented by Tadas Sileika,
PhD, Senior Scientist, Continence Care Research and Development, Hollister Incorporated
Tadas Sileika has been leading applied and translational research in functional biomaterials as a PhD candidate, more recently applying the very concepts in industry. As a graduate student, Tadas was at the forefront of functional biomaterials research inspired by plant polyphenols. During his career in industry, he has focused on utilization of advanced materials and surface modifications for novel antimicrobial strategies in wound care and continence care, aimed at reducing infection, antimicrobial resistance, and ultimately improving the quality of patients’ lives. He has also worked on bringing life-saving medical devices to emerging markets.
His efforts have led to increased awareness and understanding of relevant etiologies behind urinary tract infections for intermittent catheter users. Working closely with a global team at Hollister Incorporated, Tadas has been actively disseminating the importance of antimicrobial resistance stewardship and advanced device development in addressing ongoing and future human health issues.
In Partnership with Hollister Limited